![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Asuthkar Swapna Rao Jasti S Gondi Christopher S
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.21, Iss.2, 2012-02, pp. : 143-152
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bicalutamide: In Early-Stage Prostate Cancer
Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Preclinical development of cancer stem cell drugs
Expert Opinion on Drug Discovery, Vol. 4, Iss. 7, 2009-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs in Clinical Development for Prostate Cancer: Summary and Table
Pharmaceutical Medicine, Vol. 25, Iss. 6, 2011-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs in Clinical Development for Breast Cancer: Summary and Table
Pharmaceutical Medicine, Vol. 25, Iss. 3, 2011-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs in pancreatic cancer
By Ducreux Michel Boige Valérie Malka David
Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. :